Back

Elevated interleukin-6 and interleukin-18 concentrations predict residual inflammatory risk both before and after interleukin-1beta inhibition with canakinumab

31 August 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Immuno-inflammation as therapeutic target in heart failure Leukocytes, Inflammation, Immunity ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Paul M Ridker

Brigham and Women's Hospital, Boston (United States of America)

4 More presentations in this session

Presentation thumbnail
PD1-blocking immune checkpoint inhibitor therapy for malignant melanoma induces left ventricular dysfunction
Doctor L. Michel (Essen, DE)
Abstract
Presentation thumbnail
Th17 signature, autoimmunity and differentially expressed genes in cardiomyopathy and heart failure
Professor M. Cunningham (Oklahoma City, US)
Abstract
Presentation thumbnail
Reparative macrophage transplantation for myocardial repair: a refinement of bone marrow mononuclear cell-based therapy
Mr M. Podaru (London, GB)
Abstract Slides Video
Presentation thumbnail
Effects of a selective small-molecule formyl peptide receptor 2 agonist on post myocardial inflammation and left ventricular structure-function relationships
Doctor R. Garcia (Princeton, US)
Abstract

Access the full session

Session thumbnail
Immuno-inflammation as therapeutic target in heart failure

The Event

Event poster

ESC Congress 2019

31 August - 4 September 2019

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources